Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (221-230 of 13,976) with videos related to

Pageof 1,398
Sort By:
Leukemia|November 17, 2021
Publisher Correction: SIRT7: an influence factor in healthy aging and the development of age-dependent myeloid stem-cell disordersAlexander Kaiser, Martin Schmidt, Otmar Huber, et al.
Leukemia|November 17, 2021
Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPNFrank Stegelmann, Kai Wille, Hannah Busen, et al.
Leukemia|November 6, 2021
The tumor suppressor MIR139 is silenced by POLR2M to promote AML oncogenesisChristiaan J Stavast, Iris van Zuijen, Elena Karkoulia, et al.
Leukemia|November 7, 2021
The GPI-anchored protein CD109 protects hematopoietic progenitor cells from undergoing erythroid differentiation induced by TGF-βMikoto Tanabe, Kohei Hosokawa, Mai Anh Thi Nguyen, et al.
Leukemia|November 30, 2021
Publisher Correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumabEstefanía García-Guerrero, Ralph Götz, Sören Doose, et al.
Leukemia|November 25, 2018
MMSET I acts as an oncoprotein and regulates GLO1 expression in t(4;14) multiple myeloma cellsZhigang Xie, Jing Yuan Chooi, Sabrina Hui Min Toh, et al.
Leukemia|November 25, 2018
JAK2V617F but not CALR mutations confer increased molecular responses to interferon-α via JAK1/STAT1 activationJulia Czech, Sabrina Cordua, Barbora Weinbergerova, et al.
Leukemia|February 22, 2019
Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myelomaGaurav Goyal, S Vincent Rajkumar, Martha Q Lacy, et al.
Leukemia|February 22, 2019
Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genesMatilde Y Follo, Andrea Pellagatti, Richard N Armstrong, et al.
Leukemia|March 8, 2019
Correction: Cancer from the perspective of stem cells and misappropriated tissue regeneration mechanismsMariusz Z Ratajczak, Kamila Bujko, Aaron Mack, et al.
Pageof 1,398

Showing results (221-230 of 13,976) with videos related to

Sort By:
Pageof 1,398
Leukemia|November 17, 2021
Publisher Correction: SIRT7: an influence factor in healthy aging and the development of age-dependent myeloid stem-cell disordersAlexander Kaiser, Martin Schmidt, Otmar Huber, et al.
Leukemia|November 17, 2021
Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPNFrank Stegelmann, Kai Wille, Hannah Busen, et al.
Leukemia|November 6, 2021
The tumor suppressor MIR139 is silenced by POLR2M to promote AML oncogenesisChristiaan J Stavast, Iris van Zuijen, Elena Karkoulia, et al.
Leukemia|November 7, 2021
The GPI-anchored protein CD109 protects hematopoietic progenitor cells from undergoing erythroid differentiation induced by TGF-βMikoto Tanabe, Kohei Hosokawa, Mai Anh Thi Nguyen, et al.
Leukemia|November 30, 2021
Publisher Correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumabEstefanía García-Guerrero, Ralph Götz, Sören Doose, et al.
Leukemia|November 25, 2018
MMSET I acts as an oncoprotein and regulates GLO1 expression in t(4;14) multiple myeloma cellsZhigang Xie, Jing Yuan Chooi, Sabrina Hui Min Toh, et al.
Leukemia|November 25, 2018
JAK2V617F but not CALR mutations confer increased molecular responses to interferon-α via JAK1/STAT1 activationJulia Czech, Sabrina Cordua, Barbora Weinbergerova, et al.
Leukemia|February 22, 2019
Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myelomaGaurav Goyal, S Vincent Rajkumar, Martha Q Lacy, et al.
Leukemia|February 22, 2019
Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genesMatilde Y Follo, Andrea Pellagatti, Richard N Armstrong, et al.
Leukemia|March 8, 2019
Correction: Cancer from the perspective of stem cells and misappropriated tissue regeneration mechanismsMariusz Z Ratajczak, Kamila Bujko, Aaron Mack, et al.
Pageof 1,398